a few excerpts from a Wilsons research note published today....(maintaining 39cps risked valuation)
Anticipation isbuilding among investors and the industry ahead of efficacy results in 1Q25. We expect the stockto rally powerfully into results, noting near term updates from ADPKD program are alsoimminent.
We understand that the PLATYPUS investigators plan to share additional data at scientific meetings in Singapore (end of Nov-24) and the USA (Dec-24).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |